SlideShare a Scribd company logo
BY RAHUL DEV
SMCP MOHNA
SARASWATI MODERN COLLEGE OF PHARMACY
MOHNA , FARIDABAD
EVALUATION OF PARENTERALS
STERILIT TEST
CLARITY TEST
LEAKAGE TEST
PROGEN TEST
ASSAY
STERILITY TEST
 TEST FOR STERILITY IS DONE BY DETECTING THE
PRESENCE OF VIABLE FORMS OF
BACTERIA,FUNGI AND YEAST.
 STERILITY TEST MUST BE CARRIED OUT UNDER
STRICT ASEPTIC CONDITIONS IN ORDER TO
AVOID ACCIDENTAL CONTAMINATION OF
PRODUCT
 TESTS
 1. MEMBRANE FILTERATION METHOD
 2. DIRECT INOCULATION METHOD
PRINCIPLE
IF BACTERIA OR FUNGI ARE PLACED IN A
MEDIUM WHICH PROVIDES NUTRITIVE
MATERIAL AND WATER,AND KEPT AT A
FAVOURABLE TEMPERATURE, THE
ORGANISM WILL GROW AND THEIR
PRESENCE CAN BE INDICATED BY
TURBIDITY IN CLEAR MEDIUM.
SAMLE SIZE
NO. OF ITEMS IN THE BATCH NO OF ITEMS RECOMMENDED TO
BE TESTED
NOT MORE THAN 100 CONTAINERS 10% OR 4 WHICHEVER IS GREATER
MORE THAN 100 BUT NOT MORE
THAN 500
10 CONTAINERS
MORE THAN 500 CONTAINERS 2% OR 20 CONTAINERS WHICHEVER
IS LESS
QUNATITY OF PRODUCT TO BE USED (LIQUID)
QUANTITY OF EACH CONTAINER QUANTITY TO BE USED FOR EACH
CULTURE MEDIUM
LESS THAN 1 ML WHOLE CONTENTS OF A
CONTAINER
1 ML OR MORE BUT LESS THAN 40
ML
HALF OF CONTENTS OF A
CONTAINER
40 ML OR MORE BUT LESS THAN 100
ML
20 ML
100 ML OR MORE 10% OF CONTENT BUT NOT LESS
THAN 20 ML
QUNATITY OF PRODUCT TO BE USED
(SOLID)
QUANTITY OF EACH CONTAINER QUANTITY TO BE USED FOR EACH
CULTURE MEDIUM
LESS THAN 50 MG THE WHOLE CONTENT
50 MG OR MORE BUT LESS THAN 300
MG
HALF OF CONTENT OF A
CONTAINER
300 MG OR MORE 100 MG
MEMBRANE FILTERATION METHOD
 USED IN FOLLOWING CASES
1. OIL OR OILY PREPARATION
2. AN OINTMENT THAT CAN BE PUT INTO SOLUTION
3. A NON BACTERIOSTATIC SOLID NOT READILY
SOLUBLE IN CULTURE MEDIUM
4. A SOLUBLE POWDER OR A LIQUID THAT
POSSESSES BACTERIOSTATIC AND FUNGISTATIC
PROPERTIES
5. LIQUID PRODUCTS WHERE VOLUME IN A
CONTAINER IS 100 ML OR MORE
MEMBRANE FILTERATION METHOD
A. 1. FILTER THE SAMPLE THROUGH MEMBRANE FILTER
(POROSITY 0.45 MICRON, DIAMETER APPROX. 47 mm)
 2.REMOVE THE MEMBRANE ASEPTICALLY FROM METALLIC
HOLDER
 3. DEVIDE MEMBRANE IN TWO HALVES
 4. TRANSFER 1St HALF INTO 100 ml OF CULTURE MEDIA
MEANT FOR FUGNI AND INCUBATE AT 20-25 ⁰C FOR NOT LESS
THAN SEVEN DAYS
 5. OTHER HALF IS TRANSFERRED INTO 100 ml OF FLUID
THIOGLYCOLLATE MEDIUM AND INCUBATED AT 30-35 ⁰C FOR
NOT LESS THAN 7 DAYS.
 6. OBSERVE THE GROWTH IN THE MEDIA.
DIRECT INOCULATION METHOD
 1. SPECIFIC QUANTITY OF SAMPLE IS DRAWN
FROM CONTAINER ASETICALLY.
 2. TRANSFER THE SAMLE INTO VESSEL OF
CULTURE MEDIA.
 3. MIX THE LIQUID , INCUBATE FOR NOT LESS
THAN 14 DAYS.
 4. OBSERVE THE GROWTH IN THE MEDIUM.
OBSERVATION AND RESULT
OBSERVATION RESULT
NO EVIDENCE OF GROWTH PASSES TEST FOR STERILITY
EVIDENCE OF GROWTH RE-TESTING USING SAME NO.OF SAMPLE
,VOLUME
NO EVIDENCE OF GROWTH PASSES TEST FOR STERILITY
EVIDENCE OF GROWTH ISOLATE AND IDENTY THE ORGANISM
1. NOT READILY DISTIGUISHABLE FROM
THOSE GROWING IN CONTAINER
RESERVED IN FIRST TEST--- FAILS TEST
2. READILY DISTINGUISHABLE– SECOND
RETEST ON TWICE NO. OF SAMPLES
NO EVIDENCE OF GROWTH
EVIDENCE OF GROWTH
PASSES TEST FOR STERILITY
FAILS TEST FOR STERILITY
PYROGEN TEST
 PYROGEN TEST IS DONE TO CHECK PRESENCE OR
ABSENCE OF PYROGEN IN ALL AQUEOUS
PARENTERAL PREPARATIONS.
 PRINCIPAL—THE TEST INVOLVES THE
MEASUREMENT OF RISE IN BODY TEMPERATURE
OF RABBIT FOLLOWING I.V INJECTION OF A
STERILE SOLUTION.
 MATERIAL ---TEMPERATURE RECORDING DEVICE,
GLASS WARES, SYRINGES AND NEEDLES,
RETAINING BOXES FOR RABBITS
REQUIREMENTS
 BOX- ANIMALS ARE RETAINED ONLY BY LOOSLY FITTING –NECK
–STOCK AND REST OF THE BODY REMAINS RELATIVELY FREE SO
THAT RABBITS MAY SIT IN A NORMAL POSITION.
 THE ANIMALS MUST BE PUT 1 HOUR BEFORE THE TEST.
 ROON TEMP. WHERE TEST IS CARRIED OUT IS WITHIN THE
RANGE OF 3 ⁰C OF THE LIVING QUARTERS OF THE RABBIT.
 WITHHOLD THE FOOD FROM THE ANIMALSOVERNIGHT AND
UNTIL THE TEST IS COMPLETED
 WITHHOLD WATER DURING TEST.
 3 HEALTHY RABBITS OF EITHER SEX,EACH WEIGHING NOT LESS
THAN 1.5 KG FED ON COMPLETE BALANCED DIET
 RABBITS NOT SHOWING ANY LOSS OF WEIGHT DURING THE
WEEK PROCEEDING THE TEST.
 DO NOT USE RABBIT
 (A)HAVING TEMP. HIGHER THAN 39.8⁰C.
 (B) SHOWING TEMP. VARIATION GREATER THAN 0.2⁰C BETWEEN
TWO SUCCESIVE READINGS
METHOD
 1. TEST IS CARRIED OUT IN AN AIR CONDITIONED ROOM
 2.DISSOLVE SAMPLE ,OR DILUTE WITH, A PYROGEN FREE
SALINE
 3.WARM THE LIQUID TO APPROX. 38.5⁰C BEFORE
INJECTION
 4.AMOUNT OF SAMPLE INJECTED ACCORDING TO
MONOGRAPH.
 5. VOLUME OF INJECTION IS NOT LESS THAN 0.5 ml AND
NOT MORE THAN 10 ml PER KG OF BODY WEIGHT.
 6. CLINICAL THERMOMETER OF SENSING PROBE IS
INSERTED INTO THE RECTUM OF RABBIT FOR
RECORDING TEMPERATURE.
 7. TWO NORMAL READINGS OF RECTAL TEMP. ARE TAKEN
PRIOR TO TEST INJECTION AT AN INTERVAL OF 30 MIN
AND ITS MEAN IS CALCULATED, WHICH IS INITIAL TEMP.
OF RABBIT.
METHOD
 8. TEST SOLUTION IS INJECTED SLOWLY
THROUGH AN EAR VEIN
 9 RECORD THE TEMP. OF EACH RABBIT IN AN
INTERVAL OF 30 MINUTE FOR THREE HOURS
AFTER INJECTION.
 10 . THE DIFFERENCE BETWEEN THE INITIAL
TEMPERATURE AND MAXIMUM TEMPERATURE
RECORDED IS TAKEN TO BE ITS RESPONSE.
 11. WHEN TEMPERATURE DIFFERENCE IS
NEGATIVE , RESULT IS COUNTED AS ZERO
RESPONSE.
INTERPRETATION OF RESULT
OBSERVATION RESULT
SUM OF RESPONSES OF 3 RABBITS NOT EXCEED 1.4 ⁰C
RESPONSE OF INDIVIDUAL RABBIT IS LESS THAN 0.6 ⁰C
PASS
SUM OF RESPONSES OF 3 RABBITS EXCEEDS 1.4 ⁰C
RESPONSE OF INDIVIDUAL RABBIT IS 0.6 ⁰C OR MORE
RE TEST ON 5
OTHER RABBITS
NOT MORE THAN 3 RABBITS OUT OF 8 SHOW INDIVIDUAL
RESPONSE OF 0.6⁰C OR MORE
SUM OF RESPONSES OF GROUP OF 8 RABBITS NOT EXCEED
3.7⁰ C
PASS
THANK YOU

More Related Content

What's hot

Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
Komal Sathe
 
Preformulation Studies
Preformulation StudiesPreformulation Studies
Preformulation Studies
Teny Thomas
 
Opthalmics Preparation and its Evaluation parameters
Opthalmics Preparation and its Evaluation parametersOpthalmics Preparation and its Evaluation parameters
Opthalmics Preparation and its Evaluation parameters
Kavya S
 
Opthalmic preparation
Opthalmic preparationOpthalmic preparation
Opthalmic preparation
ibrahimussa
 
Quality control & evaluation of aerosol
Quality control & evaluation of aerosolQuality control & evaluation of aerosol
Quality control & evaluation of aerosol
Mahesh Thube Patil
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic products
Arshad Khan
 
Parenteral production
Parenteral productionParenteral production
Parenteral production
Sagar Savale
 
Bioassay of oxytocin
Bioassay of oxytocinBioassay of oxytocin
Bioassay of oxytocin
Trisha Das
 
Manufacture of soft gelatin capsule
Manufacture of soft gelatin capsuleManufacture of soft gelatin capsule
Manufacture of soft gelatin capsule
Amansharma1378
 
Evaluation of ophthalmic preparation
Evaluation of ophthalmic preparationEvaluation of ophthalmic preparation
Evaluation of ophthalmic preparation
Suneal Saini
 
capsule manufacturing defects.pptx
capsule manufacturing defects.pptxcapsule manufacturing defects.pptx
capsule manufacturing defects.pptx
Abhishek Borkar15
 
Propellants
PropellantsPropellants
Propellants
pharmacy
 
Parenteral production
Parenteral   productionParenteral   production
Parenteral production
ceutics1315
 
Formulation of eye lotions
Formulation of eye lotions Formulation of eye lotions
Formulation of eye lotions
Dheeraj Saini
 
parenterals....formulation & evaluation
parenterals....formulation & evaluationparenterals....formulation & evaluation
parenterals....formulation & evaluation
CHANDRA MOULI DUBEY
 
Parentrals , preparation and evaluation
Parentrals , preparation and evaluationParentrals , preparation and evaluation
Parentrals , preparation and evaluation
Jisna Sebastian
 
Formulation and development of parenterals
Formulation and development of parenteralsFormulation and development of parenterals
Formulation and development of parenterals
Sai Datri Arige
 
Evaluation of capsules
Evaluation of capsules Evaluation of capsules
Evaluation of capsules
SHAHINALAM360
 
Formulation & Development of Aerosol
Formulation & Development of AerosolFormulation & Development of Aerosol
Formulation & Development of Aerosol
Ashutosh Panke
 
manufacturing of parenterals
manufacturing of parenteralsmanufacturing of parenterals
manufacturing of parenterals
SUPRAJA DEEP
 

What's hot (20)

Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
 
Preformulation Studies
Preformulation StudiesPreformulation Studies
Preformulation Studies
 
Opthalmics Preparation and its Evaluation parameters
Opthalmics Preparation and its Evaluation parametersOpthalmics Preparation and its Evaluation parameters
Opthalmics Preparation and its Evaluation parameters
 
Opthalmic preparation
Opthalmic preparationOpthalmic preparation
Opthalmic preparation
 
Quality control & evaluation of aerosol
Quality control & evaluation of aerosolQuality control & evaluation of aerosol
Quality control & evaluation of aerosol
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic products
 
Parenteral production
Parenteral productionParenteral production
Parenteral production
 
Bioassay of oxytocin
Bioassay of oxytocinBioassay of oxytocin
Bioassay of oxytocin
 
Manufacture of soft gelatin capsule
Manufacture of soft gelatin capsuleManufacture of soft gelatin capsule
Manufacture of soft gelatin capsule
 
Evaluation of ophthalmic preparation
Evaluation of ophthalmic preparationEvaluation of ophthalmic preparation
Evaluation of ophthalmic preparation
 
capsule manufacturing defects.pptx
capsule manufacturing defects.pptxcapsule manufacturing defects.pptx
capsule manufacturing defects.pptx
 
Propellants
PropellantsPropellants
Propellants
 
Parenteral production
Parenteral   productionParenteral   production
Parenteral production
 
Formulation of eye lotions
Formulation of eye lotions Formulation of eye lotions
Formulation of eye lotions
 
parenterals....formulation & evaluation
parenterals....formulation & evaluationparenterals....formulation & evaluation
parenterals....formulation & evaluation
 
Parentrals , preparation and evaluation
Parentrals , preparation and evaluationParentrals , preparation and evaluation
Parentrals , preparation and evaluation
 
Formulation and development of parenterals
Formulation and development of parenteralsFormulation and development of parenterals
Formulation and development of parenterals
 
Evaluation of capsules
Evaluation of capsules Evaluation of capsules
Evaluation of capsules
 
Formulation & Development of Aerosol
Formulation & Development of AerosolFormulation & Development of Aerosol
Formulation & Development of Aerosol
 
manufacturing of parenterals
manufacturing of parenteralsmanufacturing of parenterals
manufacturing of parenterals
 

Similar to Evaluation of parenteral products

Parentral
ParentralParentral
Parentral
Maha Kiran
 
Evaluaton of parentrals
Evaluaton of parentralsEvaluaton of parentrals
Evaluaton of parentrals
SUJIT DAS
 
Sterility testing
Sterility testingSterility testing
Sterility testing
Harshali Dhaygude
 
Sterility tests
Sterility testsSterility tests
Sterility tests
Karumazzi Lohitha
 
S1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptx
S1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptxS1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptx
S1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptx
Venkatesan R - 6369851191
 
Quality control tests for parenterals ppt
Quality  control  tests  for  parenterals pptQuality  control  tests  for  parenterals ppt
Quality control tests for parenterals ppt
suraj p rajan
 
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTSIPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
SaiBapat
 
Usp 40 -71 sterility tests
Usp 40 -71 sterility testsUsp 40 -71 sterility tests
Usp 40 -71 sterility tests
Bhargava Gottam
 
Sterility testing
Sterility testingSterility testing
Parasitology paractice 4
Parasitology paractice 4Parasitology paractice 4
Parasitology paractice 4
Dr. Shameeran Bamarni
 
Quality control of parentrals
Quality control of parentralsQuality control of parentrals
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsIn Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
Sagar Savale
 
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Ms. Pooja Bhandare
 
part6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdfpart6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdf
imshrikant
 
Pyrogens test
Pyrogens testPyrogens test
Pyrogens test
Ahmad Ali
 
Aseptic Process Technology.pptx
Aseptic Process Technology.pptxAseptic Process Technology.pptx
Aseptic Process Technology.pptx
AbhishekJadhav189260
 
Sterility test
Sterility testSterility test
Sterility test
Khalid Hussain
 
ppt quality f.pptx
ppt quality f.pptxppt quality f.pptx
ppt quality f.pptx
MuhammadFarukhJaved1
 
diagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdfdiagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdf
Monish Pokra
 
Diagnostic methods of Parasites
Diagnostic methods of ParasitesDiagnostic methods of Parasites
Diagnostic methods of Parasites
SHRUTHI VASAN
 

Similar to Evaluation of parenteral products (20)

Parentral
ParentralParentral
Parentral
 
Evaluaton of parentrals
Evaluaton of parentralsEvaluaton of parentrals
Evaluaton of parentrals
 
Sterility testing
Sterility testingSterility testing
Sterility testing
 
Sterility tests
Sterility testsSterility tests
Sterility tests
 
S1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptx
S1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptxS1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptx
S1 KAVANA BB QC&QA parentrals,sugricals,opthtalmics.pptx
 
Quality control tests for parenterals ppt
Quality  control  tests  for  parenterals pptQuality  control  tests  for  parenterals ppt
Quality control tests for parenterals ppt
 
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTSIPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
 
Usp 40 -71 sterility tests
Usp 40 -71 sterility testsUsp 40 -71 sterility tests
Usp 40 -71 sterility tests
 
Sterility testing
Sterility testingSterility testing
Sterility testing
 
Parasitology paractice 4
Parasitology paractice 4Parasitology paractice 4
Parasitology paractice 4
 
Quality control of parentrals
Quality control of parentralsQuality control of parentrals
Quality control of parentrals
 
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsIn Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
 
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
 
part6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdfpart6-230110081003-34eff4a5 (1).pdf
part6-230110081003-34eff4a5 (1).pdf
 
Pyrogens test
Pyrogens testPyrogens test
Pyrogens test
 
Aseptic Process Technology.pptx
Aseptic Process Technology.pptxAseptic Process Technology.pptx
Aseptic Process Technology.pptx
 
Sterility test
Sterility testSterility test
Sterility test
 
ppt quality f.pptx
ppt quality f.pptxppt quality f.pptx
ppt quality f.pptx
 
diagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdfdiagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdf
 
Diagnostic methods of Parasites
Diagnostic methods of ParasitesDiagnostic methods of Parasites
Diagnostic methods of Parasites
 

Recently uploaded

How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
Celine George
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
eBook.com.bd (প্রয়োজনীয় বাংলা বই)
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
WaniBasim
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
Celine George
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
RAHUL
 

Recently uploaded (20)

How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
 

Evaluation of parenteral products

  • 2. SARASWATI MODERN COLLEGE OF PHARMACY MOHNA , FARIDABAD
  • 3. EVALUATION OF PARENTERALS STERILIT TEST CLARITY TEST LEAKAGE TEST PROGEN TEST ASSAY
  • 4. STERILITY TEST  TEST FOR STERILITY IS DONE BY DETECTING THE PRESENCE OF VIABLE FORMS OF BACTERIA,FUNGI AND YEAST.  STERILITY TEST MUST BE CARRIED OUT UNDER STRICT ASEPTIC CONDITIONS IN ORDER TO AVOID ACCIDENTAL CONTAMINATION OF PRODUCT  TESTS  1. MEMBRANE FILTERATION METHOD  2. DIRECT INOCULATION METHOD
  • 5. PRINCIPLE IF BACTERIA OR FUNGI ARE PLACED IN A MEDIUM WHICH PROVIDES NUTRITIVE MATERIAL AND WATER,AND KEPT AT A FAVOURABLE TEMPERATURE, THE ORGANISM WILL GROW AND THEIR PRESENCE CAN BE INDICATED BY TURBIDITY IN CLEAR MEDIUM.
  • 6. SAMLE SIZE NO. OF ITEMS IN THE BATCH NO OF ITEMS RECOMMENDED TO BE TESTED NOT MORE THAN 100 CONTAINERS 10% OR 4 WHICHEVER IS GREATER MORE THAN 100 BUT NOT MORE THAN 500 10 CONTAINERS MORE THAN 500 CONTAINERS 2% OR 20 CONTAINERS WHICHEVER IS LESS
  • 7. QUNATITY OF PRODUCT TO BE USED (LIQUID) QUANTITY OF EACH CONTAINER QUANTITY TO BE USED FOR EACH CULTURE MEDIUM LESS THAN 1 ML WHOLE CONTENTS OF A CONTAINER 1 ML OR MORE BUT LESS THAN 40 ML HALF OF CONTENTS OF A CONTAINER 40 ML OR MORE BUT LESS THAN 100 ML 20 ML 100 ML OR MORE 10% OF CONTENT BUT NOT LESS THAN 20 ML
  • 8. QUNATITY OF PRODUCT TO BE USED (SOLID) QUANTITY OF EACH CONTAINER QUANTITY TO BE USED FOR EACH CULTURE MEDIUM LESS THAN 50 MG THE WHOLE CONTENT 50 MG OR MORE BUT LESS THAN 300 MG HALF OF CONTENT OF A CONTAINER 300 MG OR MORE 100 MG
  • 9. MEMBRANE FILTERATION METHOD  USED IN FOLLOWING CASES 1. OIL OR OILY PREPARATION 2. AN OINTMENT THAT CAN BE PUT INTO SOLUTION 3. A NON BACTERIOSTATIC SOLID NOT READILY SOLUBLE IN CULTURE MEDIUM 4. A SOLUBLE POWDER OR A LIQUID THAT POSSESSES BACTERIOSTATIC AND FUNGISTATIC PROPERTIES 5. LIQUID PRODUCTS WHERE VOLUME IN A CONTAINER IS 100 ML OR MORE
  • 10. MEMBRANE FILTERATION METHOD A. 1. FILTER THE SAMPLE THROUGH MEMBRANE FILTER (POROSITY 0.45 MICRON, DIAMETER APPROX. 47 mm)  2.REMOVE THE MEMBRANE ASEPTICALLY FROM METALLIC HOLDER  3. DEVIDE MEMBRANE IN TWO HALVES  4. TRANSFER 1St HALF INTO 100 ml OF CULTURE MEDIA MEANT FOR FUGNI AND INCUBATE AT 20-25 ⁰C FOR NOT LESS THAN SEVEN DAYS  5. OTHER HALF IS TRANSFERRED INTO 100 ml OF FLUID THIOGLYCOLLATE MEDIUM AND INCUBATED AT 30-35 ⁰C FOR NOT LESS THAN 7 DAYS.  6. OBSERVE THE GROWTH IN THE MEDIA.
  • 11. DIRECT INOCULATION METHOD  1. SPECIFIC QUANTITY OF SAMPLE IS DRAWN FROM CONTAINER ASETICALLY.  2. TRANSFER THE SAMLE INTO VESSEL OF CULTURE MEDIA.  3. MIX THE LIQUID , INCUBATE FOR NOT LESS THAN 14 DAYS.  4. OBSERVE THE GROWTH IN THE MEDIUM.
  • 12. OBSERVATION AND RESULT OBSERVATION RESULT NO EVIDENCE OF GROWTH PASSES TEST FOR STERILITY EVIDENCE OF GROWTH RE-TESTING USING SAME NO.OF SAMPLE ,VOLUME NO EVIDENCE OF GROWTH PASSES TEST FOR STERILITY EVIDENCE OF GROWTH ISOLATE AND IDENTY THE ORGANISM 1. NOT READILY DISTIGUISHABLE FROM THOSE GROWING IN CONTAINER RESERVED IN FIRST TEST--- FAILS TEST 2. READILY DISTINGUISHABLE– SECOND RETEST ON TWICE NO. OF SAMPLES NO EVIDENCE OF GROWTH EVIDENCE OF GROWTH PASSES TEST FOR STERILITY FAILS TEST FOR STERILITY
  • 13. PYROGEN TEST  PYROGEN TEST IS DONE TO CHECK PRESENCE OR ABSENCE OF PYROGEN IN ALL AQUEOUS PARENTERAL PREPARATIONS.  PRINCIPAL—THE TEST INVOLVES THE MEASUREMENT OF RISE IN BODY TEMPERATURE OF RABBIT FOLLOWING I.V INJECTION OF A STERILE SOLUTION.  MATERIAL ---TEMPERATURE RECORDING DEVICE, GLASS WARES, SYRINGES AND NEEDLES, RETAINING BOXES FOR RABBITS
  • 14. REQUIREMENTS  BOX- ANIMALS ARE RETAINED ONLY BY LOOSLY FITTING –NECK –STOCK AND REST OF THE BODY REMAINS RELATIVELY FREE SO THAT RABBITS MAY SIT IN A NORMAL POSITION.  THE ANIMALS MUST BE PUT 1 HOUR BEFORE THE TEST.  ROON TEMP. WHERE TEST IS CARRIED OUT IS WITHIN THE RANGE OF 3 ⁰C OF THE LIVING QUARTERS OF THE RABBIT.  WITHHOLD THE FOOD FROM THE ANIMALSOVERNIGHT AND UNTIL THE TEST IS COMPLETED  WITHHOLD WATER DURING TEST.  3 HEALTHY RABBITS OF EITHER SEX,EACH WEIGHING NOT LESS THAN 1.5 KG FED ON COMPLETE BALANCED DIET  RABBITS NOT SHOWING ANY LOSS OF WEIGHT DURING THE WEEK PROCEEDING THE TEST.  DO NOT USE RABBIT  (A)HAVING TEMP. HIGHER THAN 39.8⁰C.  (B) SHOWING TEMP. VARIATION GREATER THAN 0.2⁰C BETWEEN TWO SUCCESIVE READINGS
  • 15. METHOD  1. TEST IS CARRIED OUT IN AN AIR CONDITIONED ROOM  2.DISSOLVE SAMPLE ,OR DILUTE WITH, A PYROGEN FREE SALINE  3.WARM THE LIQUID TO APPROX. 38.5⁰C BEFORE INJECTION  4.AMOUNT OF SAMPLE INJECTED ACCORDING TO MONOGRAPH.  5. VOLUME OF INJECTION IS NOT LESS THAN 0.5 ml AND NOT MORE THAN 10 ml PER KG OF BODY WEIGHT.  6. CLINICAL THERMOMETER OF SENSING PROBE IS INSERTED INTO THE RECTUM OF RABBIT FOR RECORDING TEMPERATURE.  7. TWO NORMAL READINGS OF RECTAL TEMP. ARE TAKEN PRIOR TO TEST INJECTION AT AN INTERVAL OF 30 MIN AND ITS MEAN IS CALCULATED, WHICH IS INITIAL TEMP. OF RABBIT.
  • 16. METHOD  8. TEST SOLUTION IS INJECTED SLOWLY THROUGH AN EAR VEIN  9 RECORD THE TEMP. OF EACH RABBIT IN AN INTERVAL OF 30 MINUTE FOR THREE HOURS AFTER INJECTION.  10 . THE DIFFERENCE BETWEEN THE INITIAL TEMPERATURE AND MAXIMUM TEMPERATURE RECORDED IS TAKEN TO BE ITS RESPONSE.  11. WHEN TEMPERATURE DIFFERENCE IS NEGATIVE , RESULT IS COUNTED AS ZERO RESPONSE.
  • 17. INTERPRETATION OF RESULT OBSERVATION RESULT SUM OF RESPONSES OF 3 RABBITS NOT EXCEED 1.4 ⁰C RESPONSE OF INDIVIDUAL RABBIT IS LESS THAN 0.6 ⁰C PASS SUM OF RESPONSES OF 3 RABBITS EXCEEDS 1.4 ⁰C RESPONSE OF INDIVIDUAL RABBIT IS 0.6 ⁰C OR MORE RE TEST ON 5 OTHER RABBITS NOT MORE THAN 3 RABBITS OUT OF 8 SHOW INDIVIDUAL RESPONSE OF 0.6⁰C OR MORE SUM OF RESPONSES OF GROUP OF 8 RABBITS NOT EXCEED 3.7⁰ C PASS